Jacob Abarca

1.5k total citations
31 papers, 1.2k citations indexed

About

Jacob Abarca is a scholar working on Geriatrics and Gerontology, Health Information Management and Family Practice. According to data from OpenAlex, Jacob Abarca has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Geriatrics and Gerontology, 8 papers in Health Information Management and 7 papers in Family Practice. Recurrent topics in Jacob Abarca's work include Pharmaceutical Practices and Patient Outcomes (15 papers), Electronic Health Records Systems (8 papers) and Medication Adherence and Compliance (7 papers). Jacob Abarca is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (15 papers), Electronic Health Records Systems (8 papers) and Medication Adherence and Compliance (7 papers). Jacob Abarca collaborates with scholars based in United States, Spain and Nigeria. Jacob Abarca's co-authors include Daniel C. Malone, Edward P. Armstrong, Amy J. Grizzle, Richard B. Lipton, Philip D. Hansten, John E. Murphy, Raymond L. Woosley, Grant H. Skrepnek, Jeffrey M. Rothschild and Rita Snyder and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medical Care and Journal of the American Medical Informatics Association.

In The Last Decade

Jacob Abarca

30 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Jacob Abarca 682 287 249 209 196 31 1.2k
A.W. Lenderink 458 0.7× 318 1.1× 128 0.5× 178 0.9× 134 0.7× 20 1.2k
Kristine M. Gleason 789 1.2× 639 2.2× 222 0.9× 128 0.6× 104 0.5× 11 1.1k
Hanna M. Seidling 646 0.9× 147 0.5× 362 1.5× 191 0.9× 139 0.7× 102 1.2k
Amy J. Grizzle 1.1k 1.6× 284 1.0× 288 1.2× 374 1.8× 129 0.7× 36 1.7k
Pamela L. Smithburger 479 0.7× 286 1.0× 107 0.4× 208 1.0× 205 1.0× 72 1.8k
Marianne Lisby 753 1.1× 628 2.2× 201 0.8× 125 0.6× 133 0.7× 62 1.3k
J. Calop 555 0.8× 253 0.9× 102 0.4× 105 0.5× 91 0.5× 77 901
Steven Shadowitz 668 1.0× 493 1.7× 81 0.3× 136 0.7× 173 0.9× 18 987
Rita Shane 681 1.0× 426 1.5× 111 0.4× 162 0.8× 105 0.5× 80 1.1k
Robert K. Hallisey 804 1.2× 870 3.0× 420 1.7× 223 1.1× 93 0.5× 10 1.5k

Countries citing papers authored by Jacob Abarca

Since Specialization
Citations

This map shows the geographic impact of Jacob Abarca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Abarca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Abarca more than expected).

Fields of papers citing papers by Jacob Abarca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Abarca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Abarca. The network helps show where Jacob Abarca may publish in the future.

Co-authorship network of co-authors of Jacob Abarca

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Abarca. A scholar is included among the top collaborators of Jacob Abarca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Abarca. Jacob Abarca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaoxue, et al.. (2022). Effectiveness, safety and treatment adherence of biosimilar follow‐on insulin in diabetes management. Diabetes Obesity and Metabolism. 24(10). 1989–1997. 2 indexed citations
2.
Ko, Yu, Daniel C. Malone, Grant H. Skrepnek, et al.. (2008). Prescribers??? Knowledge of and Sources of Information for Potential??Drug-Drug Interactions. Drug Safety. 31(6). 525–536. 85 indexed citations
3.
Anthony, Marietta, Jacob Abarca, Rick A. Rehfeld, et al.. (2008). Gender and Age Differences in Medications Dispensed from a National Chain Drugstore. Journal of Women s Health. 17(5). 735–743. 27 indexed citations
4.
Duby, Jeremiah J., et al.. (2007). Impact of delayed initiation of erythropoietin in critically ill patients. SHILAP Revista de lepidopterología. 7(1). 1–1. 1 indexed citations
5.
Malone, Daniel C., Jacob Abarca, Grant H. Skrepnek, et al.. (2007). Pharmacist Workload and Pharmacy Characteristics Associated With the Dispensing of Potentially Clinically Important Drug-Drug Interactions. Medical Care. 45(5). 456–462. 95 indexed citations
6.
Snyder, Rita, et al.. (2007). Reliability evaluation of the adapted National Coordinating Council Medication Error Reporting and Prevention (NCC MERP) index. Pharmacoepidemiology and Drug Safety. 16(9). 1006–1013. 185 indexed citations
7.
8.
Skrepnek, Grant H., Edward P. Armstrong, Daniel C. Malone, et al.. (2006). Workload and Availability of Technology in Metropolitan Community Pharmacies. Journal of the American Pharmacists Association. 46(2). 154–160. 14 indexed citations
9.
Abarca, Jacob, et al.. (2006). Evaluation of the Performance of Drug-Drug Interaction Screening Software in Community and Hospital Pharmacies. Journal of Managed Care Pharmacy. 12(5). 383–389. 75 indexed citations
10.
Abarca, Jacob, Daniel C. Malone, Grant H. Skrepnek, et al.. (2006). Community Pharmacy Managers' Perception of Computerized Drug—Drug Interaction Alerts. Journal of the American Pharmacists Association. 46(2). 148–153. 21 indexed citations
11.
Patanwala, Asad E., et al.. (2006). Pharmacologic Management of Constipation in the Critically Ill Patient. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(7). 896–902. 39 indexed citations
12.
Ko, Yu, Jacob Abarca, Daniel C. Malone, et al.. (2006). Practitioners' Views on Computerized Drug--Drug Interaction Alerts in the VA System. Journal of the American Medical Informatics Association. 14(1). 56–64. 76 indexed citations
13.
Abarca, Jacob & Sulabha Ramachandran. (2005). PEER REVIEWED: Using Community Indicators to Assess Nutrition in Arizona-Mexico Border Communities. Preventing Chronic Disease. 2(1). 1 indexed citations
14.
Abarca, Jacob & Sulabha Ramachandran. (2005). Using community indicators to assess nutrition in Arizona-Mexico border communities.. PubMed. 2(1). A06–A06. 12 indexed citations
15.
Abarca, Jacob, et al.. (2005). PCV16 INCREMENTAL EFFECTS OF CONCURRENT PHARMACOTHERAPEUTIC REGIMENS FOR HEART FAILURE ON HOSPITALIZATIONS AND COSTS. Value in Health. 8(3). 265–265. 3 indexed citations
16.
Abarca, Jacob, Daniel C. Malone, Edward P. Armstrong, et al.. (2004). Concordance of Severity Ratings Provided in Four Drug Interaction Compendia. Journal of the American Pharmacists Association. 44(2). 136–141. 169 indexed citations
17.
Malone, Daniel C., Edward P. Armstrong, Jacob Abarca, et al.. (2004). Identification of Serious Drug–Drug Interactions: Results of the Partnership to Prevent Drug–Drug Interactions. Journal of the American Pharmacists Association. 44(2). 142–151. 149 indexed citations
18.
Abarca, Jacob, Daniel C. Malone, Edward P. Armstrong, & Woodie Zachry. (2004). Angiotensin‐Converting Enzyme Inhibitor Therapy in Patients with Heart Failure Enrolled in a Managed Care Organization: Effect on Costs and Probability of Hospitalization. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 24(3). 351–357. 9 indexed citations
19.
Abarca, Jacob, Daniel C. Malone, Edward P. Armstrong, Amy J. Grizzle, & Marc D. Cohen. (2004). Longitudinal Analysis of the Use of Etanercept Versus Infliximab Determined From Medical Chart Audit. Journal of Managed Care Pharmacy. 10(6). 538–542. 15 indexed citations
20.
Abarca, Jacob & Edward P. Armstrong. (2001). Improving the Use of Data Sources in Disease Management Programs. Disease Management & Health Outcomes. 9(9). 459–471. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.W. Lenderink Breakdown of academic impact, for papers by Kristine M. Gleason Breakdown of academic impact, for papers by Hanna M. Seidling Breakdown of academic impact, for papers by Amy J. Grizzle Breakdown of academic impact, for papers by Pamela L. Smithburger Breakdown of academic impact, for papers by Marianne Lisby Breakdown of academic impact, for papers by J. Calop Breakdown of academic impact, for papers by Steven Shadowitz Breakdown of academic impact, for papers by Rita Shane Breakdown of academic impact, for papers by Robert K. Hallisey
Rankless by CCL
2026